Denmark Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Denmark Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report “Denmark Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Denmark. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Denmark’s pharmaceutical and biotechnology industries are among the largest and most advanced in the world as they offer attractive economic prospects to various local and multinational companies, including cooperative R&D initiatives, locations for European headquarters, and strategic partnerships. The availability of a highly automated and sophisticated pharmaceutical and biotech production landscape, a friendly corporate climate, and a top-notch research environment, among others, promote the expansion of pharmaceutical manufacturing facilities in Denmark. In terms of US dollars, Denmark’s pharmaceutical market increased from $3.3 billion in 2015 to $3.9 billion in 2020 at a Compound Annual Growth Rate (CAGR) of 3.5%. It was forecast to increase to $4.0 billion in 2021. In terms of Danish Krone (DKK), Denmark’s pharmaceutical market increased from DKK21.9 billion in 2015 to DKK25.3 billion in 2020, at a CAGR of 2.9%. It was forecast to increase to DKK26 billion in 2021. Denmark is one of Europe's top countries for medical technology. It offers attractive collaborations in R&D, design and innovation expertise, test and demonstration facilities, public-private partnerships, and high-tech manufacturing. In 2016, the medical devices market in Denmark was worth $1.4 billion, which increased at a CAGR of 6.3% to $1.9 billion in 2021. In 2021, the Danish government revealed its new life sciences industrial strategy, comprising 38 new projects across seven major industries. The strategy emphasized improving the environment for R&D and using health data, as well as securing a highly educated workforce and laying the framework for the country's industry's worldwide expansion, which aimed to benefit Denmark’s patients and economy.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Denmark, and includes -

• An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
• Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, GlaxoSmithKline (GSK), Sanofi, Novo Nordisk, and Leo.
• Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Zimmer Biomet, Getinge, and Coloplast.
• An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in the healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
• Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure.
• An overview of the opportunities for and challenges to growth in the Danish healthcare market.

• Develop business strategies by understanding the trends shaping and driving the Indonesian healthcare market
• Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Indonesian healthcare market in the future
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
• Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership